Perigon Wealth Management, LLC Esperion Therapeutics, Inc. Transaction History

Perigon Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $34,540 - $50,723	-1,375 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$24.2 - $35.76 $33,275 - $49,170	1,375 New	1,375 $36,000
Q2 2018 Aug 07, 2018	SELL	$36.2 - $76.4 $61,069 - $128,886	-1,687 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $1,978 - $2,422	30 Added 1.81%	1,687 $122,000
Q3 2017 Dec 05, 2017	BUY	$43.8 - $52.77 $72,576 - $87,439	1,657	1,657 $83,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.